Herbas VPB

Print
EN | LT
LT - COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT
EN - COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/4704
A61K 39/395
A61K 39/00
A61K 45/06
A61P 35/00
C07K 16/28
European patent
(11) Number of the document 3268031
(13) Kind of document T
(96) European patent application number 16705122.6
Date of filing the European patent application 2016-02-16
(97) Date of publication of the European application 2018-01-17
(45) Date of publication and mention of the grant of the patent 2020-11-04
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2016/053288
Date 2016-02-16
PCT application publication
(87) Number WO 2016/146329
Date 2016-09-22
Priority applications
(30) Number Date Country code
15290069 2015-03-13 EP
Inventors
(72)
SOARES, José Amauri, FR
CHETAILLE, Eric, FR
NAKHLE, Jessica, FR
SCHMIDLIN, Fabien, FR
Grantee
(73) Active Biotech AB, Scheelevägen 22, 223 63 Lund, SE
Title
(54) COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT
  COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT
Last update date 2021-05-26